APA (7th ed.) Citation

Borchmann, P., & Meißner, J. (2014). Addition of Rituximab to BEACOPP(escalated) to improve the outcome of early interim PET positive advanced stage Hodgkin lymphoma patients: Second planned interim analysis of the HD18 study. Blood, 124(21), .

Chicago Style (17th ed.) Citation

Borchmann, Peter, and Julia Meißner. "Addition of Rituximab to BEACOPP(escalated) to Improve the Outcome of Early Interim PET Positive Advanced Stage Hodgkin Lymphoma Patients: Second Planned Interim Analysis of the HD18 Study." Blood 124, no. 21 (2014).

MLA (9th ed.) Citation

Borchmann, Peter, and Julia Meißner. "Addition of Rituximab to BEACOPP(escalated) to Improve the Outcome of Early Interim PET Positive Advanced Stage Hodgkin Lymphoma Patients: Second Planned Interim Analysis of the HD18 Study." Blood, vol. 124, no. 21, 2014.